AR049269A1 - Macrolidos unidos por esteres, utiles para el tratamiento de infecciones microbianas. procesos de preparacion y composiciones farmaceuticas. - Google Patents
Macrolidos unidos por esteres, utiles para el tratamiento de infecciones microbianas. procesos de preparacion y composiciones farmaceuticas.Info
- Publication number
- AR049269A1 AR049269A1 ARP050101810A ARP050101810A AR049269A1 AR 049269 A1 AR049269 A1 AR 049269A1 AR P050101810 A ARP050101810 A AR P050101810A AR P050101810 A ARP050101810 A AR P050101810A AR 049269 A1 AR049269 A1 AR 049269A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen
- optionally substituted
- alkoxy
- group
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000000813 microbial effect Effects 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 19
- 239000001257 hydrogen Substances 0.000 abstract 19
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 14
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 10
- 150000002431 hydrogen Chemical group 0.000 abstract 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical group 0.000 abstract 6
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 5
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 2
- 101001043818 Mus musculus Interleukin-31 receptor subunit alpha Proteins 0.000 abstract 2
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical group [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052731 fluorine Chemical group 0.000 abstract 1
- 239000011737 fluorine Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
- 229940041033 macrolides Drugs 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 abstract 1
- 125000004001 thioalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56940204P | 2004-05-06 | 2004-05-06 | |
| US58111804P | 2004-06-18 | 2004-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049269A1 true AR049269A1 (es) | 2006-07-12 |
Family
ID=34967616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050101810A AR049269A1 (es) | 2004-05-06 | 2005-05-04 | Macrolidos unidos por esteres, utiles para el tratamiento de infecciones microbianas. procesos de preparacion y composiciones farmaceuticas. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080255060A1 (https=) |
| EP (1) | EP1756135B1 (https=) |
| JP (1) | JP2007536371A (https=) |
| AR (1) | AR049269A1 (https=) |
| AT (1) | ATE439367T1 (https=) |
| AU (1) | AU2005240849B2 (https=) |
| BR (1) | BRPI0510328A (https=) |
| CA (1) | CA2566085A1 (https=) |
| DE (1) | DE602005015963D1 (https=) |
| ES (1) | ES2331739T3 (https=) |
| IL (1) | IL178876A0 (https=) |
| MA (1) | MA28640B1 (https=) |
| MX (1) | MXPA06012923A (https=) |
| NO (1) | NO20065662L (https=) |
| RU (1) | RU2006143051A (https=) |
| WO (1) | WO2005108412A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1638549A4 (en) | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | NEW ANTIBACTERIAL AGENTS |
| WO2006120541A1 (en) * | 2005-05-10 | 2006-11-16 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Ether linked macrolides useful for the treatment of microbial infections |
| CA2670482C (en) * | 2006-12-05 | 2011-10-11 | Pfizer Inc. | Motilide polymorphs |
| EP2214484A4 (en) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS |
| JP5711135B2 (ja) | 2008-10-24 | 2015-04-30 | センプラ ファーマシューティカルズ，インコーポレイテッド | 胃腸疾患を治療するための方法 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| ES2608285T3 (es) | 2009-09-10 | 2017-04-07 | Cempra Pharmaceuticals, Inc. | Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC |
| CN102917708B (zh) | 2010-05-20 | 2015-11-25 | 森普拉制药公司 | 制备大环内酯和酮内酯及其中间体的方法 |
| EP2613630A4 (en) | 2010-09-10 | 2014-01-15 | Cempra Pharmaceuticals Inc | HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES |
| NZ700182A (en) | 2012-03-27 | 2017-02-24 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| AU2014239959A1 (en) | 2013-03-14 | 2015-10-01 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| CN105188712A (zh) | 2013-03-15 | 2015-12-23 | 森普拉制药公司 | 用于制备大环内酯抗菌剂的收敛方法 |
| GB201608236D0 (en) | 2016-05-11 | 2016-06-22 | Fidelta D O O | Seco macrolide compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0127349D0 (en) * | 2001-11-14 | 2002-01-02 | Glaxo Group Ltd | Macrolides |
| GB0225384D0 (en) * | 2002-10-31 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
| ES2278319T3 (es) * | 2003-05-13 | 2007-08-01 | Glaxo Group Limited | Nuevos compuestos con 14 y 15 miembros en el anillo. |
| GB0310984D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| GB0310979D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| WO2006120541A1 (en) * | 2005-05-10 | 2006-11-16 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Ether linked macrolides useful for the treatment of microbial infections |
-
2005
- 2005-05-02 WO PCT/IB2005/001186 patent/WO2005108412A1/en not_active Ceased
- 2005-05-02 AT AT05739739T patent/ATE439367T1/de not_active IP Right Cessation
- 2005-05-02 CA CA002566085A patent/CA2566085A1/en not_active Abandoned
- 2005-05-02 MX MXPA06012923A patent/MXPA06012923A/es unknown
- 2005-05-02 BR BRPI0510328-2A patent/BRPI0510328A/pt not_active IP Right Cessation
- 2005-05-02 DE DE602005015963T patent/DE602005015963D1/de not_active Expired - Lifetime
- 2005-05-02 RU RU2006143051/04A patent/RU2006143051A/ru not_active Application Discontinuation
- 2005-05-02 US US11/568,562 patent/US20080255060A1/en not_active Abandoned
- 2005-05-02 AU AU2005240849A patent/AU2005240849B2/en not_active Ceased
- 2005-05-02 JP JP2007512549A patent/JP2007536371A/ja not_active Withdrawn
- 2005-05-02 ES ES05739739T patent/ES2331739T3/es not_active Expired - Lifetime
- 2005-05-02 EP EP05739739A patent/EP1756135B1/en not_active Expired - Lifetime
- 2005-05-04 AR ARP050101810A patent/AR049269A1/es not_active Application Discontinuation
-
2006
- 2006-10-26 IL IL178876A patent/IL178876A0/en unknown
- 2006-12-01 MA MA29498A patent/MA28640B1/fr unknown
- 2006-12-06 NO NO20065662A patent/NO20065662L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1756135A1 (en) | 2007-02-28 |
| IL178876A0 (en) | 2007-03-08 |
| EP1756135B1 (en) | 2009-08-12 |
| ES2331739T3 (es) | 2010-01-14 |
| DE602005015963D1 (de) | 2009-09-24 |
| NO20065662L (no) | 2007-01-16 |
| CA2566085A1 (en) | 2005-11-17 |
| US20080255060A1 (en) | 2008-10-16 |
| ATE439367T1 (de) | 2009-08-15 |
| AU2005240849A1 (en) | 2005-11-17 |
| MA28640B1 (fr) | 2007-06-01 |
| MXPA06012923A (es) | 2007-07-18 |
| RU2006143051A (ru) | 2008-06-20 |
| WO2005108412A1 (en) | 2005-11-17 |
| AU2005240849B2 (en) | 2008-10-23 |
| JP2007536371A (ja) | 2007-12-13 |
| BRPI0510328A (pt) | 2007-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049269A1 (es) | Macrolidos unidos por esteres, utiles para el tratamiento de infecciones microbianas. procesos de preparacion y composiciones farmaceuticas. | |
| AR044304A1 (es) | Compuesto de macrolido de 14 y 15 miembros sustituido en la posicion 4'', procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende | |
| AR069412A1 (es) | Derivados de pirimidina, proceso para prepararlos, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades virales, bacterianas y alergicas, entre otras. | |
| AR038240A1 (es) | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion | |
| AR066492A1 (es) | Derivados de imidazoquinolina, proceso para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de enfermedades virales, bacterianas, alergicas y distintos tipos de canceres. | |
| AR062677A1 (es) | Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden | |
| AR086094A1 (es) | Derivados nucleosidicos 2’-azido sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar enfermedades virales por vhc | |
| AR044045A1 (es) | Compuesto de piperidincarbonilpiperazina, composicion farmaceutica que lo comprende, su uso para la elaboracion de un medicamento y procedimiento para su preparacion | |
| AR086096A1 (es) | Derivados de nucleosidos 2’-ciano sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales | |
| PE20060381A1 (es) | Analogos de dipeptidos inhibidores de la hepatitis c | |
| AR048292A1 (es) | Derivados de quinolina y composiciones farmaceuticas utiles para el tratamiento del cancer | |
| AR047444A1 (es) | Peptidos macrociclicos activos contra el virus de la hepatitis c | |
| AR040336A1 (es) | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto | |
| AR064414A1 (es) | Derivados de 1-azoniabiciclo[2, 2, 2]octano y 1-azabiciclo[2, 2, 2]oct-3-ilo, un proceso para su preparacion, una composicion farmaceutica que los comprende, procedimiento de obtencion de la misma, su uso en la elaboracion de un medicamento para el tratamiento de epoc y un producto farmaceutico que | |
| AR061651A1 (es) | Analogos de piridina ii | |
| AR040335A1 (es) | Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto | |
| AR038172A1 (es) | Compuesto de ciclohexano y ciclohexeno, su uso para preparar una composicion farmaceutica, dicha composicion farmaceutica, procedimiento para preparar el compuesto y compuestos intermediarios en dicho procedimiento | |
| AR063804A1 (es) | Compuestos de azoniabiciclo[2.2.2]octano | |
| AR036492A1 (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3, composiciones farmaceuticas y el uso de dichos inhibidores para la elaboracion de un medicamento para el tratamiento de enfermedades androgeno dependientes | |
| AR079231A1 (es) | Derivados de imidazoquinolina | |
| PE20090630A1 (es) | Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion | |
| AR086095A1 (es) | Derivados de nucleosidos 2’-sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales | |
| AR063240A1 (es) | Derivados de n-aril pirazol,composiciones farmaceuticas que los contienen y usos para el tratamiento de la diabetes tipo2,y enfermedades relacionadas. | |
| AR082391A1 (es) | Inhibidores biciclicos de acetil-coa y usos de los mismos | |
| AR048315A1 (es) | Compuestos heterociclicos inhibidores de la produccion de citocinas; composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades inflamatorias y oncologicas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FB | Suspension of granting procedure |